Recursion Pharmaceuticals Inc Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA). Nvidia Invested $50 million into This AI Drug Discovery Biotech www.nasdaq.com/articles/nvidia-invested-$50-million-into-this-ai-drug-discovery-biotech www.nasdaq.com/articles/nvidia-invested-$50-million-into-this-ai-drug-discover…